Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ilya Zyuzgin"'
Autor:
Aleksei Koviazin, Larisa Filatova, Ilya Zyuzgin, Anna Artemyeva, Ilia Poliatskin, Leonid Kramynin, Tatiana Semiglazova
Publikováno v:
HemaSphere, Vol 7, p e146925c (2023)
Externí odkaz:
https://doaj.org/article/8a2eb22ba70c49929d293687dc347b1e
Autor:
Svetlana Elkhova, Larisa Filatova, Ilya Zyuzgin, Margarita Motalkina, Stanislav Volchenkov, Anna Zverkova, Irina Ishmatova, Julia Nikulina, Leonid Kramynin, Tatiana Semiglazova
Publikováno v:
HemaSphere, Vol 7, p e8342511 (2023)
Externí odkaz:
https://doaj.org/article/aed2429badae471394899c7474525cb7
Autor:
Stanislav Volchenkov, Larisa Filatova, Ishmatova Irina, Ilya Zyuzgin, Zverkova Anna, Svetlana Elkhova, Aleksei Koviazin, Tatiana Semiglazova, Leonid Kramynin, Nikulina July, Dobrovolskaya Evgenia
Publikováno v:
HemaSphere, Vol 7, p e13179db (2023)
Externí odkaz:
https://doaj.org/article/484c513bcc9d462f862fb1ba879479c3
Autor:
Andrey Chekalov, Marina Popova, Ivan Tsygankov, Yuliya Rogacheva, Nikita Volkov, Anastasia Beynarovich, Kirill Lepik, Marina Demchenkova, Marina Grigorieva, Tatiana Schneider, Yuliya Kopeikina, Natalia Medvedeva, Ilya Zyuzgin, Elena Pavlyuchenko, Alexander Levanov, Alexander Myasnikov, Natalia Mikhailova, Vadim Baykov, Alexander Kulagin
Publikováno v:
HemaSphere, Vol 6, Pp 39-39 (2022)
Externí odkaz:
https://doaj.org/article/26386b5289f6419dada0fa0feec7305f
Autor:
Anna Artemeva, Ilya Zyuzgin, I. L. Polyatskin, Margarita Motalkina, Yevgeniya Kharchenko, Yuliya Chudinovskikh, Tatyana Semiglazova, Filatova Lv, G. S. Kireeva, Yuliya Oleynik
Publikováno v:
Problems in oncology. 66:79-89
Aim: To identify incidence and prognostic impact of different IHC and molecular genetic markers in Diffuse Large B-cell lymphoma. Methods: We analyzed 215 patients with DLBCL who received treatment from 2008 to 2016. We assess expression of different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd68cdebb25e711fbb097962cd005f72
https://doi.org/10.37469/0507-3758-2020-66-1-79-89
https://doi.org/10.37469/0507-3758-2020-66-1-79-89
Autor:
Yu. A. Oleynik, I. L. Polyatskin, Yu.A. Chudinovskikh Chudinovskikh, Filatova Lv, Evgeniya Vladimirovna Kharchenko, G. S. Kireyeva, A.S. Artemyeva, Ilya Zyuzgin, T.Yu. Semiglazova Semiglazova, M. S. Motalkina
Publikováno v:
Scopus-Elsevier
Медицинский совет, Vol 0, Iss 19, Pp 158-164 (2019)
Медицинский совет, Vol 0, Iss 19, Pp 158-164 (2019)
Aim. To evaluate impact of different clinical features on prognosis in Diffuse Large B-cell lymphoma (DLBCL) patients and to determine potential correlation between IHC markers (double-expression of c-myc, bcl-2 and p53) on unfavorable clinical chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c713e7de5d3e5bde7b5bb8e12372e3cb
https://doi.org/10.21518/2079-701x-2019-19-158-164
https://doi.org/10.21518/2079-701x-2019-19-158-164
Autor:
Svetlana Kuleva, Tatyana Semiglazova, A. Subora, Margarita Motalkina, Yevgeniya Kharchenko, Sergey Alekseev, I.V. Ishmatova Ishmatova, Yuliya Oleynik, Ilya Zyuzgin, Yuliya Chudinovskikh, Sergey Shalaev, Filatova Lv, Polina Shilo
Publikováno v:
Problems in oncology. 64:414-418
High dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) is suggested as the standard of treatment of patients with relapsed or refractory Hodgkin’s lymphoma (HL) providing long-term disease-free survival in over 50 % of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4df59b03b607752f12c61b9ecc70e39e
https://doi.org/10.37469/0507-3758-2018-64-3-414-418
https://doi.org/10.37469/0507-3758-2018-64-3-414-418
Autor:
Aleksei Koviazin, Larisa Filatova, Ilya Zyuzgin, Anna Artemyeva, Margarita Motalkina, Yulia Chudinovskikh, Stanislav Volchenkov, Ilia Poliatskin, Evgeniya Cherkasova, Sergey Shalaev, Irina Ishmatova, Anna Zverkova, Maksim Ghanzin, Darya Burda, Tatiana Semiglazova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75d579011f02e21c2522dd35ba8208cd
https://doi.org/10.1016/s2152-2650(21)01505-6
https://doi.org/10.1016/s2152-2650(21)01505-6
Autor:
Sergey Alekseev, I.V. Ishmatova Ishmatova, Ilya Zyuzgin, Anna Artemeva, Polina Shilo, Filatova Lv, Tatyana Semiglazova, Yevgeniya Kharchenko, Margarita Motalkina
Publikováno v:
Problems in oncology. 63:326-328
Currently there is no single approach to treatment for aggressive diffuse large-cell B-cell lymphoma (Double-HIT and Triple-HIT). Accumulated world data remain controversial and, given the unfavorable prognosis in this subgroup, high-dose chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2625dc2edea54fdc32bad76821c5e256
https://doi.org/10.37469/0507-3758-2017-63-2-326-328
https://doi.org/10.37469/0507-3758-2017-63-2-326-328
Autor:
John Catalano, Peter Ganly, Tadeusz Robak, M. Wayne Saville, Sergey I. Moiseev, Anna Dmoszynska, Ilya Zyuzgin, Christian H. Geisler, Krzysztof Warzocha, Nancy Valente, Philippe Solal-Celigny, Caroline Dartigeas, Javier Loscertales, Marco Montillo, Jörg Maurer, Michael Wenger, Loree Larratt, Myriam Mendila, Boris V. Afanasiev, András Rosta
Publikováno v:
Journal of Clinical Oncology. 28:1756-1765
Purpose Rituximab, a monoclonal antibody that targets the CD20 cell surface antigen, has clinical activity in patients with non-Hodgkin's lymphoma and other B-lymphocyte disorders when administered alone or in combination with chemotherapy. Promising
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60f542cb3bb8bd7dbf936f723452ed4
https://doi.org/10.1200/jco.2009.26.4556
https://doi.org/10.1200/jco.2009.26.4556